Utah Medical Products Inc. (Nasdaq:UTMD) changes in financial results compared to the same time period in the prior calendar year. International sales in 3Q 2011 and 9M 2011, respectively, were up 217% and 142%. With the addition of Femcare, international sales were 51% of total consolidated 3Q 2011 sales, and 49% of 9M 2011 sales. Femcare's sales were 63% of total international sales in 3Q 2011, and 55% in 9M 2011.



Read the full article and the disclaimer at:http://crwefinance.com/?p=21060